Evidence map›Paper›PMID 31666122›Full record

ArticleSkeletal muscle2019

LIM and cysteine-rich domains 1 (LMCD1) regulates skeletal muscle hypertrophy, calcium handling, and force.

Duarte M S Ferreira, Arthur J Cheng, Leandro Z Agudelo, Igor Cervenka, Thomas Chaillou, Jorge C Correia, Margareta Porsmyr-Palmertz, Manizheh Izadi, Alicia Hansson, Vicente Martínez-Redondo and 7 more

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Zfp697 is an RNA-binding protein that regulates skeletal muscle inflammation and remodeling.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Microproteins in skeletal muscle: hidden keys in muscle physiology.Journal of cachexia, sarcopenia and muscle · 2022
    Review
  16. Exploring the Muscle Metabolomics in the Mouse Model of Sepsis-Induced Acquired Weakness.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Duarte M S FerreiraMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Arthur J ChengMolecular Muscle Physiology and Pathophysiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Leandro Z AgudeloMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Igor CervenkaMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Thomas ChaillouMolecular Muscle Physiology and Pathophysiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Jorge C CorreiaMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Margareta Porsmyr-PalmertzMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Manizheh IzadiMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Alicia HanssonMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Vicente Martínez-RedondoMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Paula Valente-SilvaMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Amanda T Pettersson-KleinMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Jennifer L EstallDivision of Cardiovascular and Metabolic Disease, Institut de recherches cliniques de Montreal (IRCM), Montreal, QC, Canada.
Matthew M RobinsonDivision of Endocrinology, Diabetes and Nutrition, Mayo Clinic, Rochester, MN, 55905, USA.
K Sreekumaran NairDivision of Endocrinology, Diabetes and Nutrition, Mayo Clinic, Rochester, MN, 55905, USA.
Johanna T LannerMolecular Muscle Physiology and Pathophysiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden.
Jorge L RuasMolecular & Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, SE-171 77, Stockholm, Sweden. jorge.ruas@ki.se.ORCID 0000-0002-1110-2606
Karolinska Institutet · SEMayo Clinic · USMontreal Clinical Research Institute · CAÖrebro University · SEYork University · CA

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
TECHNOLOGY NMR SPECTROSCOPYU24DK100469 · NIDDK · MAYO CLINIC ROCHESTER · PI NAIR, K SREEKUMARAN · 2013 to 2017
$9.0M
NCATS NIH HHS UL1 TR000135NIDDK NIH HHS U24 DK100469NIDDK NIH HHS U24DK100469NIH HHS R01AG09531NIH HHS T32DK7352
6 · The paper itself

Abstract

backgroundSkeletal muscle mass and strength are crucial determinants of health. Muscle mass loss is associated with weakness, fatigue, and insulin resistance. In fact, it is predicted that controlling muscle atrophy can reduce morbidity and mortality associated with diseases such as cancer cachexia and sarcopenia.

methodsWe analyzed gene expression data from muscle of mice or human patients with diverse muscle pathologies and identified LMCD1 as a gene strongly associated with skeletal muscle function. We transiently expressed or silenced LMCD1 in mouse gastrocnemius muscle or in mouse primary muscle cells and determined muscle/cell size, targeted gene expression, kinase activity with kinase arrays, protein immunoblotting, and protein synthesis levels. To evaluate force, calcium handling, and fatigue, we transduced the flexor digitorum brevis muscle with a LMCD1-expressing adenovirus and measured specific force and sarcoplasmic reticulum Ca

resultsHere, we identify LIM and cysteine-rich domains 1 (LMCD1) as a positive regulator of muscle mass, that increases muscle protein synthesis and fiber size. LMCD1 expression in vivo was sufficient to increase specific force with lower requirement for calcium handling and to reduce muscle fatigue. Conversely, silencing LMCD1 expression impairs calcium handling and force, and induces muscle fatigue without overt atrophy. The actions of LMCD1 were dependent on calcineurin, as its inhibition using cyclosporine A reverted the observed hypertrophic phenotype. Finally, we determined that LMCD1 represses the expression of myoregulin, a known negative regulator of muscle performance. Interestingly, we observed that skeletal muscle LMCD1 expression is reduced in patients with skeletal muscle disease.

conclusionsOur gain- and loss-of-function studies show that LMCD1 controls protein synthesis, muscle fiber size, specific force, Ca

Indexed as

AnimalsCalcineurinCalcineurin InhibitorsCalciumCells, CulturedCo-Repressor ProteinsGene Expression RegulationHumansHypertrophyLIM Domain ProteinsMiceMice, Inbred C57BLMice, SCIDMice, TransgenicMuscle Fibers, SkeletalMuscle ProteinsCalcineurinCalcineurin InhibitorsCalciumCo-Repressor ProteinsLIM Domain ProteinsLMCD1 protein, humanLmcd1 protein, mouseMuscle Proteinsmyoregulin, mouseRNA, MessengerCalcineurinCalciumForceHypertrophyLMCD1Skeletal muscle

Identifiers

PMID31666122
PMCPMC6822430
OpenAlexW2988977772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.